• No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation

  • May 22 2024
  • Duración: 16 m
  • Podcast

No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation  Por  arte de portada

No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation

  • Resumen

  • Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three trials showed promising results, with 40% of patients experiencing at least an 8-week transfusion-free interval.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.